Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer
- PMID: 8593822
- DOI: 10.1210/endo.137.2.8593822
Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer
Abstract
The clinical manifestations of patients with resistance to thyroid hormone result from inhibition of the functions of wild-type thyroid hormone receptors (wTRs) by the dominant negative effect of mutant TR beta 1 receptors (mTR beta 1). One of the proposed mechanisms by which mTR beta 1 exerts its dominant negative action is via formation of the putative inactive wTR beta 1/mTR beta 1 heterodimer. However, the nature of the wTR beta 1/mTR beta 1 heterodimer is poorly understood. The present study characterizes the wTR beta 1/mTR beta 1 heterodimer by electrophoretic mobility shift assay. The mutant TR beta 1 used was PV, which contains a frame shift mutation in the C-terminal part of TR beta 1 and has less than 1% of the T3 binding affinity of the wTR beta 1. Because of the difficulty in resolving wTR beta 1 and mutant PV dimers, we used a truncated wTR beta 1 in which the A/B domain was deleted (delta TR beta 1) to demonstrate the formation of the heterodimer on thyroid hormone response elements (TREs) in which the half-site binding motifs are oriented in an inverted repeat (F2), a direct repeat separated by four nucleotides (DR4), or an inverted repeat (Pal). Deletion of the A/B domain had no effect on the binding of T3 and TREs to wTR beta 1. In the presence of equal amounts of delta TR beta 1 and PV, three types of molecular complexes. delta TR beta 1 homodimer, delta TR beta 1/PV heterodimer, and PV homodimer bound to each TRE in a ratio of approximately 1:2:1. The identities of these complexes were confirmed by their ability to be supershifted by anti-TR beta 1 and/or anti-PV antibodies. delta TR beta 1/PV heterodimer formation varied with different TREs. The ratio of apparent affinity constant (Ka) in the binding of delta TR beta 1/PV to TREs was F2:DR4:Pal = approximately 6:2:1. The effect of T3 on delta TR beta 1/PV heterodimer formation was TRE dependent. No T3-induced dissociation was observed for the delta TR beta 1/PV heterodimer when bound to F2 and Pal. In contrast, the delta TR beta 1/PV heterodimer bound to DR4 was dissociated by T3 with an ED50 of 3.9 +/- 0.9 nM. The T3-induced dissociation of delta TR beta 1 homodimer bound to F2, DR4, and Pal had ED50 values of 4.1 +/- 1.2, 1.3 +/- 0.3, and more than 100 nM, respectively. By transfection assays, the dominant negative action of PV was found to be TRE dependent with the rank order of F2 >> Pal > ME (a DR4-like TRE in the rat malic enzyme gene). Taken together, these results indicate a strong correlation between wTR beta 1/mTR beta 1 heterodimer formation and the dominant negative potency of PV. These results suggest that the wTR beta 1/mTR beta 1 heterodimer could play an important role in the dominant negative action of mTR beta 1.
Similar articles
-
Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action.Endocrinology. 1997 Apr;138(4):1456-63. doi: 10.1210/endo.138.4.5067. Endocrinology. 1997. PMID: 9075702
-
Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.Mol Endocrinol. 1993 Oct;7(10):1319-30. doi: 10.1210/mend.7.10.8264663. Mol Endocrinol. 1993. PMID: 8264663
-
Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.Endocrinology. 1996 Oct;137(10):4082-6. doi: 10.1210/endo.137.10.8828460. Endocrinology. 1996. PMID: 8828460
-
The thyroid hormone receptors: molecular basis of thyroid hormone resistance.Horm Res. 1992;38(1-2):57-61. doi: 10.1159/000182487. Horm Res. 1992. PMID: 1306518 Review.
-
Molecular diagnosis and characterization of thyroid hormone resistance syndromes.Thyroid. 1991 Winter;1(4):361-7. doi: 10.1089/thy.1991.1.361. Thyroid. 1991. PMID: 1668726 Review.
Cited by
-
Mutational Landscape of Resistance to Thyroid Hormone Beta (RTHβ).Mol Diagn Ther. 2019 Jun;23(3):353-368. doi: 10.1007/s40291-019-00399-w. Mol Diagn Ther. 2019. PMID: 30976996 Review.
-
An F-domain introduced by alternative splicing regulates activity of the zebrafish thyroid hormone receptor alpha.Gen Comp Endocrinol. 2008 Jan 1;155(1):176-89. doi: 10.1016/j.ygcen.2007.04.012. Epub 2007 Apr 27. Gen Comp Endocrinol. 2008. PMID: 17583703 Free PMC article.
-
Resistance to thyroid hormone.Rev Endocr Metab Disord. 2000 Jan;1(1-2):97-108. doi: 10.1023/a:1010072605757. Rev Endocr Metab Disord. 2000. PMID: 11704998 Review. No abstract available.
-
Audiological alterations in resistance to thyroid hormone syndrome: emphasizing lifelong assessment.Arch Endocrinol Metab. 2025 Feb 13;69(1):e240078. doi: 10.20945/2359-4292-2024-0078. Arch Endocrinol Metab. 2025. PMID: 39945573 Free PMC article.
-
Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone.Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13209-14. doi: 10.1073/pnas.230285997. Proc Natl Acad Sci U S A. 2000. PMID: 11069286 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous